Nordamerika-Marktprognose für digitales Genom bis 2027 – Auswirkungen von COVID-19 und regionale Analyse nach Produkten (DNA/RNA-Analyse, Sequenzierungschips, Sequenzierungs- und Analyseinstrumente, Probenvorbereitungsinstrumente, Sequenzierungs- und Analysesoftware); Anwendung (Diagnostik, Landwirtschaft, akademische Forschung, Arzneimittelentwicklung, personalisierte Medizin, andere Anwendungen); Endbenutzer (Diagnose- und forensische Labore, akademische Forschungsinstitute, Krankenhäuser, andere Endbenutzer) und Land
Markteinführung
Das digitale Genom ist eine vollständige digitale Anordnung genetischen Materials, das in einer Zelle oder einem Organismus vorkommt. Dies ist eine einfachere Möglichkeit, Informationen über chronische Krankheiten zu sammeln und von Experten genutzt zu werden, um einen besseren Einblick in genetische Störungen zu erhalten. Die digitale Genomik beschäftigt sich mit Genen & ihre Rollen und zielt darauf ab, die Faktoren hinter chronischen Störungen zu identifizieren und anzugehen, um sie zu beheben. Diese Technologie hat eine Revolte in der erfindungszentrierten Forschung und Entwicklung ausgelöst. Systembiologie, um Einblicke in die komplexesten genetischen Systeme zu ermöglichen.
Marktüberblick und -dynamik
Der nordamerikanische digitale Genommarkt soll bis 2027 9.594,71 Millionen US-Dollar erreichen, gegenüber 4.999,94 Millionen US-Dollar im Jahr 2019. Es wird erwartet, dass der Markt im Zeitraum 2019–2027 mit einer jährlichen Wachstumsrate von 8,7 % wächst. Faktoren wie die Es wird erwartet, dass die zunehmende Prävalenz chronischer Krankheiten und die zunehmende Finanzierung der Genomik das Wachstum des digitalen Genommarkts ankurbeln werden. Allerdings wird der Markt im Prognosezeitraum wahrscheinlich durch Risikofaktoren wie Sicherheits- und Vertraulichkeitsprobleme der Patientendaten beeinträchtigt.
Wichtige Marktsegmente
In Bezug auf das Produkt hatte das Segment Sequenzierungs- und Analysegeräte im Jahr 2019 den größten Anteil am nordamerikanischen Markt für digitales Genom. Den größten Anteil hatte das Segment Diagnostik und forensische Labore Anteil am nordamerikanischen digitalen Genommarkt, nach Endbenutzern, im Jahr 2019. In Bezug auf die Anwendung hatte das Diagnostiksegment im Jahr 2019 den größten Anteil am nordamerikanischen digitalen Genommarkt.
Wichtige Quellen und Unternehmen aufgeführt
Mehrere wichtige primäre und sekundäre Quellen im Zusammenhang mit dem Bericht über den digitalen Genommarkt in Nordamerika sind die Zentren der Weltgesundheitsorganisation (WHO). of Disease Control and Prevention (CDC), International Diabetes Federation (IDF), National Human Genome Research Institute (NHGRI), OECD Health Statistics und andere.
Gründe für den Kauf Bericht
- Es vermittelt ein Verständnis der digitalen Genommarktlandschaft in Nordamerika und identifiziert digitale Genommarktsegmente, die am wahrscheinlichsten eine starke Rendite garantieren.
- Es hilft, der Konkurrenz immer einen Schritt voraus zu sein, indem es die sich ständig verändernde Wettbewerbslandschaft für den digitalen Genommarkt in Nordamerika versteht.
- Es hilft Planen Sie effizient Fusionen und Übernahmen sowie Partnerschaftsabkommen im digitalen Genommarkt, indem Sie Marktsegmente mit den vielversprechendsten wahrscheinlichen Verkäufen identifizieren.
- Es erleichtert fundierte Geschäftsentscheidungen durch eine einfühlsame und umfassende Analyse digitaler Daten Genommarktleistung verschiedener Segmente im Zusammenhang mit dem digitalen Genommarkt in Nordamerika.
- Es bietet eine Umsatzprognose für den digitalen Genommarkt des Marktes basierend auf verschiedenen Segmenten für den Zeitraum von 2019 bis 2027.
SEGMENTIERUNG DES DIGITALEN GENOMMARKTS IN NORDAMERIKA
Nach Produkt
- Sequenzierungs- und Analysegeräte
- DNA/RNA-Analyse
- Sequenzierungs- und Analysesoftware
- Sequenzierungschips
- Probenvorbereitungsinstrumente
Nach Anwendung
- Diagnose
- Arzneimittelforschung
- Akademische Forschung
- Personalisierte Medizin
- Landwirtschaft
- Andere
Nach Endbenutzer
- Diagnostik- und forensische Labore
- Akademische Forschungsinstitute
- Krankenhäuser
- Andere
Nach Land
- USA
- Kanada
- Mexiko
Unternehmensprofile
- BD
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- GenomeMe
- NanoString Technologies, Inc,
- GenMark Diagnostics, Inc
- Perkin Elmer, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Digital Genome Market – By Product
1.3.2 North America Digital Genome Market – By Application
1.3.3 North America Digital Genome Market– By End User
1.3.4 North America Digital Genome Market – By Country
2. North America Digital Genome Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Digital Genome Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Digital Genome Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Digital Genome Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Funding for Genomics
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Key Market Restraints
5.2.1 Security and Confidentiality Issue
5.3 Key Market Opportunities
5.3.1 Increasing Technological Advancement in Digital Genome Field
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicines
5.5 Impact Analysis
6. Digital Genome Market – North America Analysis
6.1 North America Digital Genome Market Revenue Forecasts and Analysis
7. North America Digital Genome Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 North America Digital Genome Market, By Product 2019 & 2027 (%)
7.2.1 North America Digital Genome Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 DNA/RNA Analysis
7.3.1 Overview
7.3.2 North America DNA/RNA Analysis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Sequencing and Analyzer Instruments
7.4.1 Overview
7.4.1.1 North America Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Sequencing and Analysis Software
7.5.1 Overview
7.5.2 North America Sequencing and Analysis Software Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Sequencing Chips
7.6.1 Overview
7.6.2 North America Sequencing Chips Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Sample Prep Instruments
7.7.1 Overview
7.7.2 North America Sample Prep Instruments Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Digital Genome Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 North America Digital Genome Market, By Application 2019 & 2027 (%)
8.2.1 North America Digital genome Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Diagnostics
8.3.1 Overview
8.3.2 North America Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 North America Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Academic Research
8.5.1 Overview
8.5.2 North America Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Personalized Medicine
8.6.1 Overview
8.6.2 North America Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Agricultural
8.7.1 Overview
8.7.2 North America Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Digital Genome Market Analysis – By End-User
9.1 Overview
9.2 North America Digital Genome Market, By End-User 2019-2027 (%)
9.2.1 North America Digital Genome Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Diagnostics and Forensic Labs
9.3.1 Overview
9.3.2 North America Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Academic Research Institutes
9.4.1 Overview
9.4.2 North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Hospitals
9.5.1 Overview
9.5.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Digital genome Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Digital genome Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.4 North America: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.5 North America: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.6 North America: Digital Genome Market, by Country, 2019 & 2027 (%)
10.1.7 US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.7.3 US: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.7.4 US: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.8 Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Canada: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.8.4 Canada: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.9 Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.9.3 Mexico: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.9.4 Mexico: Digital Genome Market, by End User , 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Digital Genome Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Illumina, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GenomeMe
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 NanoString Technologies, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BD
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GenMark Diagnostics, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Perkin Elmer, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Digital Genome Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Digital genome Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Digital Genome Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. North America Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 6. North America Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 7. US Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. US Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 9. US Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Digital Genome Market
LIST OF FIGURES
Figure 1. Digital Genome Market Segmentation
Figure 2. North America Digital Genome Market Overview
Figure 3. The Sequencing and Analyzer Instruments Segment Held Largest Share of Digital Genome Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Digital Genome Market - Leading Country Markets (US$ Mn)
Figure 6. Digital Genome Market - North America PEST Analysis
Figure 7. Digital Genome Market Impact Analysis of Driver and Restraints
Figure 8. North America Digital Genome Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Digital Genome Market, By Product 2019 & 2027 (%)
Figure 10. North America DNA/RNA Analysis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Sequencing and Analysis Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Sequencing Chips Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Sample Prep Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Digital Genome Market, By Application 2019 & 2027 (%)
Figure 16. North America Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Digital Genome Market, by End-User 2019 & 2027 (%)
Figure 23. North America Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. North America: Digital Genome Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. North America Digital Genome Market Revenue and Forecast to 2027 (USD Million)
Figure 29. North America: Digital Genome Market, by Country, 2019 & 2027 (%)
Figure 30. US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America Digital Genome Market
- BD
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- GenomeMe
- NanoString Technologies, Inc,
- GenMark Diagnostics, Inc
- Perkin Elmer, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America digital genome market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America digital genomemarket, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.